This Meeting is Proceeding as Planned
COVID-19 Update

Home

Join Us at the Rx and Illicit Drug Summit - Learn More
Engage in Discussion, Explore Solutions, Empower Change.

Stimulants have become increasingly prevalent in overdoses and addiction throughout our communities. Counterfeit prescription pills are being laced with illicit drugs in alarming amounts. We can’t afford to lose more ground, for more lives to be lost.

Join us for our sister conference, the Rx and Illicit Drug Summit, taking place April 10-13, 2023 in Atlanta. Learn more here.

Visit Rx Summit Website
Stimulant Summit
The Facts About the Stimulant Epidemic

The opioid epidemic made headlines while the stimulant crisis loomed closely behind.

5 Million+
People Are Current Cocaine Users.
5 Million
Americans Misuse Prescription Stimulants
2.5 Million
Americans Ages 12+ Reported Past-Year Methamphetamine Use
0
The number of FDA-approved medications to treat stimulant use disorder
View Agenda
Who Should Attend?

The Cocaine, Meth & Stimulant Summit is designed and accredited for professionals in the fields of addiction, behavioral, and mental health and law enforcement:

Physicians
Nurses
Physician assistants
Pharmacists
Private practice therapists
Psychologists
Counselors, social workers, interventionists
Law enforcement personnel including chiefs of police, sheriffs, detectives, and other public safety officials
Public health and prevention officials
Federal, state, and local officials and lawmakers
2022 Featured Speakers

Led by multi-disciplinary experts from across the nation, the Cocaine, Meth & Stimulant Summit provides the most extensive educational experience for professionals on the frontlines of this rising epidemic.

Rahul Gupta, MD
Director, Office of National Drug Control Policy
Robert Califf, MD
Commissioner, Food and Drugs Administration
Nora Volkow, MD
Director, National Institute on Drug Abuse
Debra Houry, MD
Acting Principal Deputy Director, Centers for Disease Control and Prevention
Director, National Center for Injury Prevention and Control
Jennifer Smith
Secretary
Pennsylvania Department of Drug and Alcohol Programs
John Eadie, MPA
Coordinator, Public Health and Prescription Drug Monitoring Program Project; National Emerging Threats Initiative, A National HIDTA Initiative
Daniel Ciccarone, MD
Professor of Family and Community Medicine, University of California, San Francisco
More Information
The Cocaine, Meth & Stimulant Summit has been eye opening in regards to the different ways we can help people in our communities. It has shed light on the right way to make changes. Stimulant Summit has lit a fire inside me that I look forward to spreading in my community, turning the tides in our battle against drugs.

Jim Thompson, Sergeant at Elwha Klallam Tribe

Great dichotomy between law enforcement and clinical tracks, offering a collaborative view of how to best approach and assist those who are struggling. The biggest issue is deciding which track to attend.

Nicholas Svetlauskas, Bureau Chief of Addiction at State of Indiana

2019 was my second Stimulant Summit and I now consider it an annual “must attend” event for the latest information on stimulants from a wide range of authoritative sources. Great and timely information.

Lyle Fried, CEO at Transformations / Addiction DNA